Connection

PEDRO PIEDRA to Lung

This is a "connection" page, showing publications PEDRO PIEDRA has written about Lung.
Connection Strength

0.463
  1. Development of a cotton rat-human metapneumovirus (hMPV) model for identifying and evaluating potential hMPV antivirals and vaccines. Antiviral Res. 2005 Apr; 66(1):57-66.
    View in: PubMed
    Score: 0.133
  2. Longitudinal host transcriptional responses to SARS-CoV-2 infection in adults with extremely high viral load. PLoS One. 2025; 20(1):e0317033.
    View in: PubMed
    Score: 0.131
  3. Enhanced pulmonary pathology associated with the use of formalin-inactivated respiratory syncytial virus vaccine in cotton rats is not a unique viral phenomenon. Vaccine. 1993 Nov; 11(14):1415-23.
    View in: PubMed
    Score: 0.060
  4. Mucosal vaccines with STING-agonist liposomal formulations inhibit RSV (respiratory syncytial virus) replication in cotton rats. Vaccine. 2025 May 22; 56:127183.
    View in: PubMed
    Score: 0.033
  5. The Human Nose Organoid Respiratory Virus Model: an Ex Vivo Human Challenge Model To Study Respiratory Syncytial Virus (RSV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pathogenesis and Evaluate Therapeutics. mBio. 2021 02 22; 13(1):e0351121.
    View in: PubMed
    Score: 0.025
  6. Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection. Antimicrob Agents Chemother. 2016 01; 60(1):6-13.
    View in: PubMed
    Score: 0.017
  7. Glycan variants of a respiratory syncytial virus antibody with enhanced effector function and in vivo efficacy. Proc Natl Acad Sci U S A. 2014 Apr 22; 111(16):5992-7.
    View in: PubMed
    Score: 0.015
  8. Mechanism of lung injury in cotton rats immunized with formalin-inactivated respiratory syncytial virus. Vaccine. 1989 Feb; 7(1):34-8.
    View in: PubMed
    Score: 0.011
  9. Immune response to experimentally induced infection with respiratory syncytial virus: possible role in the development of pulmonary disease. J Gen Virol. 1989 Feb; 70 ( Pt 2):325-33.
    View in: PubMed
    Score: 0.011
  10. T lymphocytes contribute to antiviral immunity and pathogenesis in experimental human metapneumovirus infection. J Virol. 2008 Sep; 82(17):8560-9.
    View in: PubMed
    Score: 0.010
  11. Immunologic aspects of surface infections in the lung. J Pediatr. 1986 May; 108(5 Pt 2):817-23.
    View in: PubMed
    Score: 0.009
  12. Disseminated adenovirus disease in immunocompromised and immunocompetent children. Clin Infect Dis. 1998 Nov; 27(5):1194-200.
    View in: PubMed
    Score: 0.005
  13. Effect of respiratory syncytial virus infection on the uptake of and immune response to other inhaled antigens. Proc Soc Exp Biol Med. 1988 Jun; 188(2):191-7.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.